York, J., Maeda, M., Lara, G., Kandula, M., & Apparsundaram, S. (2025). Preclinical Evaluation of CLX-155A: A Novel 5-FU and Valproic Acid Pro-drug in Nude Mouse Model for Activity in Triple-Negative Breast Cancer. Medical Research Archives, 13(4). doi:10.18103/mra.v13i4.6470